Latest Articles
- Effective but inaccessible antiobesity medications: A call for sharing responsibility for improving access to evidence-based care
The potentially transformative benefits of second-generation obesity medications have yet to be realized because many patients lack access to these medications.
A man with chronic limb-threatening ischemia and no revascularization options: Can we save his foot?The patient’s right foot was edematous with extensive, dry-appearing gangrene of the big toe, and no pedal pulses were felt.
- The history of blood cultures: From the research laboratory to the bedside
Efforts to prove that bacteria cause endocarditis paved the way for use of blood cultures in the clinic.
- The PRECISE trial: How should patients with chest pain be tested?
Can a risk score identify individuals with chest pain who can safely forego testing?
- It’s time for a little history of medicine—introducing a new feature in CCJM
This month, we debut a feature focused on topics in the history of medicine, authored by Cleveland Clinic rheumatologist Adam Brown, MD.
- Continuous glucose monitoring: High-tech devices still need some low-tech backup
High-end devices that monitor patients’ physiology offer many benefits, but device malfunctions and disruptions are not rare events.
- Fixed drug eruption due to ibuprofen
The patient had a 2-month history of a lesion on the left groin that caused a burning sensation.
- Using continuous glucose monitoring data in daily clinical practice
The authors review data elements of the Ambulatory Glucose Profile Report, a standardized format for displaying glucose monitoring data, and present a structured approach to using the data to optimize glycemic management.
- Sorting out aortic aneurysms: A team enterprise
Aortic aneurysms present considerable diagnostic and treatment challenges owing to their diverse causes, incomplete understanding of pathogenesis, and variations in presentation and disease course.